Concepedia

Vaccine Durability

Vaccine Durability is a metric that quantifies the length of time a vaccine maintains protective efficacy against infection or disease under real-world conditions, distinguishing it from related measures of immunogenicity or short-term effectiveness.

123

Publications

6.2K

Citations

1.1K

Authors

300

Institutions

Publications per year

2017–2026

71

Variants

Vaccine Efficacy Duration

Parents

Publications

123

Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐up

Irja Davidkin, Sari Jokinen, Mia Broman et al. · The Journal of Infectious Diseases · 2008 · 326 citations · Full text

, , +16

Covid-19 Vaccine Effectiveness in New York State

New England Journal of Medicine · 2021 · 284 citations · Full text

, , +17

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

Floriane Gallais, Pierre Gantner, Timothée Bruel et al. · EBioMedicine · 2021 · 239 citations · Full text

, , +15

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

Mahboobeh Safaeian, Carolina Porras, Yuanji Pan et al. · Cancer Prevention Research · 2013 · 221 citations · Full text

, , +17

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

Wendy A. Keitel, Thomas R. Cate, R. B. Couch et al. · Vaccine · 1997 · 221 citations

, , +14

1–5 of 123

Authors

1.1K

  1. RE
    Robert E. Weibel

    University of Pennsylvania, United States

    5 publications · 91 citations

    5

    h-index

  2. MR
    M. R. Hilleman

    United States Military Academy, United States

    5 publications · 91 citations

    5

    h-index

  3. EB
    Eugene B. Buynak

    United States Military Academy, United States

    5 publications · 91 citations

    5

    h-index

  4. LA
    Lígia A. Pinto

    National Cancer Institute, United States

    4 publications · 554 citations

    4

    h-index

  5. AH
    Allan Hildesheim

    National Cancer Institute, United States

    4 publications · 554 citations

    4

    h-index

1–5 of 1.1K

Institutions

300

  1. Emory University

    Atlanta, United States

    9 h-index

    17 publications

    667 citations

  2. University of Washington

    Seattle, United States

    7 h-index

    23 publications

    1.4K citations

  3. Fred Hutch Cancer Center

    Seattle, United States

    7 h-index

    28 publications

    1.3K citations

  4. National Institutes of Health

    Bethesda, United States

    6 h-index

    30 publications

    1.6K citations

  5. National Institute of Allergy and Infectious Diseases

    Bethesda, United States

    6 h-index

    17 publications

    476 citations

  6. Baylor College of Medicine

    Houston, United States

    6 h-index

    11 publications

    931 citations

  7. University of Pennsylvania

    Philadelphia, United States

    5 h-index

    13 publications

    211 citations

  8. GlaxoSmithKline (Belgium)

    Wavre, Belgium

    5 h-index

    9 publications

    479 citations

1–8 of 300

Venues

  1. Vaccine

    19 publications · 897 citations

    15

    h-index

  2. The Journal of Infectious Diseases

    JID · 6 publications · 667 citations

    6

    h-index

  3. JAMA

    6 publications · 225 citations

    6

    h-index

  4. New England Journal of Medicine

    NEJM · 5 publications · 459 citations

    5

    h-index

  5. medRxiv

    Repository · 5 publications · 84 citations

    5

    h-index

1–5